Genen­tech-part­nered Gen­e­sis Ther­a­peu­tics inks newest AI dis­cov­ery deal with Eli Lil­ly

A Stan­ford biotech rubbed el­bows with Genen­tech in 2020, reach­ing a deal with the big-name biotech just over 18 months ago. And now, the AI out­fit is in its sec­ond part­ner­ship with Big Phar­ma.

Gen­e­sis Ther­a­peu­tics se­cured a deal with big phar­ma Eli Lil­ly, the com­pa­ny an­nounced on Tues­day — to dis­cov­er ther­a­pies “across a range of ther­a­peu­tic ar­eas,” ac­cord­ing to a state­ment put out by the biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER